News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genizon BioSciences Inc. Secures $31 Million in Additional Financing



1/7/2008 8:30:35 AM

MONTREAL--(BUSINESS WIRE)--Genizon BioSciences today announced the closing of its Series E financing in the amount of CAD$31 million. The lead investor is BTF B.V. of Haarlem, The Netherlands, a venture capital fund focused on late stage biotechnology companies. Several other existing investors also participated. The Company’s funding since its founding in 1999 totals over $130 million.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES